申请人:Pfizer Inc.
公开号:US20040229874A1
公开(公告)日:2004-11-18
The present invention relates to compounds of formula I,
1
and the pharmaceutically acceptable salts thereof.
These compounds are useful as psychotherapeutic agents.
本发明涉及公式I的化合物及其药用盐。这些化合物可用作心理治疗药物。